Multiple Myeloma Market Outlook To 2033

Multiple myeloma, also known as myeloma, is a type of bone marrow cancer. Bone marrow is the spongy tissue at the centre of some bones that produces the body`s blood cells. It`s called multiple myeloma as the cancer often affects several areas of the body, such as the spine, skull, pelvis and ribs.

Report forecasts the multiple myeloma market to reach $40.41B by 2033 (from $21.78B in 2024), driven by rising cases and therapy advances.